Humacyte, Inc. - 8-K Filing
On May 4, 2026, Humacyte received notice from Nasdaq that its stock had closed below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Select Market over a 30-business-day period ending May 1, 2026. It has until November 2, 2026 to regain compliance by achieving a closing bid price of at least $1.00 per share for 10 consecutive business days. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On May 4, 2026, Humacyte, Inc)
Tickers: $HUMA